|
MTMR4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.97200042354007E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.567900E-02 |
| Stage1-vs-Stage3 |
1.459430E-03 |
| Stage1-vs-Stage4 |
1.079770E-02 |
| Stage2-vs-Stage3 |
2.374100E-04 |
| Stage2-vs-Stage4 |
2.806800E-04 |
| Stage3-vs-Stage4 |
6.414600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.06640260458357E-11 |
| Normal-vs-Asian |
1.97508676080815E-12 |
| Caucasian-vs-AfricanAmerican |
9.025000E-01 |
| Caucasian-vs-Asian |
1.254580E-01 |
| AfricanAmerican-vs-Asian |
2.931200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.701000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.4238999999946E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.024800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.686000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.171800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.715000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.630600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.43220007970046E-10 |
| Classical-VS-Follicular |
2.07509999999855E-05 |
| Classical-VS-Other |
8.219200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.66167080095647E-12 |
| Tall-VS-Other |
9.362200E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.323000E-01 |
| Follicular-VS-Normal |
2.51059950606702E-10 |
| Other-VS-Normal |
7.65209999999961E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.424850E-03 |
|
|
